Endocrinology News and Research

Latest Endocrinology News and Research

Exercise during pregnancy shown to restore metabolic health

A new study has shown that exercise can restore key tissues and reduce the risk of metabolic disorders such as type 2 diabetes.

2 Sep 2019

ARNI therapy trial misses target in heart failure, may have selective benefit only

Heart failure with preserved ejection fraction (HFpEF) is a common condition, affecting millions of people and resulting in significant illness and death. No effective treatments have been developed for this condition.

2 Sep 2019

Microbes linked to heart attacks finds study

A study revealed at the ESC Congress 2019 held in Paris last weekend reveals that abnormal microbe population in the body may lead to impairment of the stable coronary plaques and lead them to be dislodged leading to a heart attack. The abstract titled, “A different microbial signature in plaque and gut of patients presenting with ACS: a possible role for coronary instability” was presented on the 31st of August 2019.

1 Sep 2019

LDL cholesterol levels should be lowered as much as possible to prevent cardiovascular risk

Low-density lipoprotein cholesterol levels should be lowered as much as possible to prevent cardiovascular disease, especially in high and very high risk patients.

31 Aug 2019

New discovery may help identify type 1 diabetes earlier than is currently possible

Type 1 diabetes, an autoimmune disease that typically emerges before the age of 20, wipes out the body's ability to produce insulin--a hormone that's essential to life. Diagnosis often comes after symptoms arise, at which point the disease has taken hold.

30 Aug 2019

ACC to join fellow experts at NCD Café to kick off Global Week for Actions on NCDs

Noncommunicable diseases, such as heart disease and diabetes, are the leading cause of death around the world. NCDs already account for over 70 percent of deaths, with this percentage only expected to increase in the coming years.

30 Aug 2019

Diet can alter efficacy of type-2 diabetes drug via its action on gut bacteria, study shows

Research published in Cell on 29th August by the groups of Filipe Cabreiro from the MRC London Institute of Medical Sciences and Imperial College and Christoph Kaleta from Kiel University in Germany has demonstrated that diet can alter the effectiveness of a type-2 diabetes drug via its action on gut bacteria.

30 Aug 2019

Managing fluid volume and salt losses during a marathon may help avoid post-race kidney injury

Legend states that after the Greek army defeated the invading Persian forces near the city of Marathon in 490 B.C.E., the courier Pheidippides ran to Athens to report the victory and then immediately dropped dead.

30 Aug 2019

Adults with cerebral palsy twice as likely to develop cardiovascular, chronic respiratory diseases

Adults with cerebral palsy are about twice as likely to develop cardiovascular disease and chronic respiratory disease compared to adults without cerebral palsy, according to a new study led by RCSI (Royal College of Surgeons in Ireland) and Brunel University London.

29 Aug 2019

Islet-on-a-Chip to study the fundamental biology of diabetes

By combining two powerful technologies, scientists are taking diabetes research to a whole new level. In a study led by Harvard University's Kevin Kit Parker, microfluidics and human, insulin-producing beta cells have been integrated in an "Islet-on-a-Chip".

29 Aug 2019

Mount Sinai researchers discover drug resistance signature in Crohn's disease

By mapping out more than 100,000 immune cells in patients with Crohn's disease, Mount Sinai researchers have discovered a signature of cells that are involved in a type of the disease that does not respond to treatment, according to a study published in Cell in August.

29 Aug 2019

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with MannKind Corporation, a biopharmaceutical company focused on inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

From Tanner Pharma Group 29 Aug 2019

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

Recent research into over 20 million births concluded that babies born by Cesarean section are more likely to develop autism has divided the medical community.

29 Aug 2019

New type 2 diabetes drug associated with reduced risk of heart failure and death

The new type of drugs for type 2 diabetes, the so-called SGLT2 inhibitors, are associated with a reduced risk of heart failure and death as well as of major cardiovascular events, a major Scandinavian registry study led from Karolinska Institutet reports in The BMJ.

29 Aug 2019

Gout patients have higher risk of advanced kidney disease, study finds

Patients with gout are at increased risk of chronic kidney disease and kidney failure, according to new University of Limerick (UL), Ireland led research.

29 Aug 2019

MUSC researchers narrow down risk of preeclampsia to a specific phenotype

The force of blood traveling through your arteries and veins determines much of your heart health. High blood pressure can lead to heart disease, heart failure, heart attack, stroke and chronic kidney disease, and when it's coupled with type 1 diabetes and pregnancy, it can put both the mother and the baby at risk.

29 Aug 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019

A single cholesterol-derived molecule promotes adiposity

A single cholesterol-derived molecule, called 27-hydroxycholesterol (27HC), lurks inside your bloodstream and will increase your body fat, even if you don't eat a diet filled with red meat and fried food. That kind of diet, however, will increase the levels of 27HC and body weight.

29 Aug 2019

Depressive symptoms linked to increased disabilities, chronic health conditions among aging minorities

More than 50 percent of older Chinese American immigrants experience depressive symptoms linked to increased disabilities and chronic health conditions, according to two new Rutgers studies.

28 Aug 2019

Endocrinology News and Research

Latest Endocrinology News and Research

Exercise during pregnancy shown to restore metabolic health

ARNI therapy trial misses target in heart failure, may have selective benefit only

Microbes linked to heart attacks finds study

LDL cholesterol levels should be lowered as much as possible to prevent cardiovascular risk

New discovery may help identify type 1 diabetes earlier than is currently possible

ACC to join fellow experts at NCD Café to kick off Global Week for Actions on NCDs

Diet can alter efficacy of type-2 diabetes drug via its action on gut bacteria, study shows

Managing fluid volume and salt losses during a marathon may help avoid post-race kidney injury

Adults with cerebral palsy twice as likely to develop cardiovascular, chronic respiratory diseases

Islet-on-a-Chip to study the fundamental biology of diabetes

Mount Sinai researchers discover drug resistance signature in Crohn's disease

Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Claims that cesarean sections increase the risk of autism are “highly unlikely”, say experts

New type 2 diabetes drug associated with reduced risk of heart failure and death

Gout patients have higher risk of advanced kidney disease, study finds

MUSC researchers narrow down risk of preeclampsia to a specific phenotype

How much control is too much in type 1 diabetes?

A single cholesterol-derived molecule promotes adiposity

Depressive symptoms linked to increased disabilities, chronic health conditions among aging minorities

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Endocrinology News and Research

Latest Endocrinology News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in